---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013398"
form_type: "8-K"
ticker: "FOXO"
cik: "0001812360"
company_name: "FOXO TECHNOLOGIES INC."
filed_at: "2025-09-15T23:59:59+00:00"
generated_at: "2026-05-17T06:39:17.053038+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# FOXO Technologies signs agreement to acquire Vector Biosource Inc.

## Summary
- Purchase price: $500K cash, 60K Series E Preferred ($1.5M stated value), warrants for $2M common stock at 10% premium to closing price.
- Up to additional 80K Series E Preferred shares ($2M stated value) contingent on future revenue and cash collection milestones.
- FOXO to fund up to $1.2M for Vector's growth initiatives; Vector had Q2 2025 net revenue of ~$225K ($0.9M annualized).
- Closing subject to due diligence, finalization of warrant and employment agreements; expected as soon as practical.
- Vector provides data and biospecimen sourcing for biotech, clinical research, and pharma industries.

## SEC filing metadata
- accession: 0001493152-25-013398
- form_type: 8-K
- ticker: FOXO
- cik: 0001812360
- company_name: FOXO TECHNOLOGIES INC.
- filed_at: 2025-09-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812360/000149315225013398/0001493152-25-013398-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812360/000149315225013398/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013398
- JSON: https://secwatch.observer/filing/0001493152-25-013398.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013398.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.